Dermatology
The AJMC® Dermatology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the skin, hair, and nails.
Latest News
Approved Hidradenitis Suppurativa Treatments and Pipeline Show Similar Efficacy, Safety Without Head-to-Head Trials
Sun Exposure Risks Brought to Light During UV Safety Awareness Month
FDA Expands Dupilumab Approval as First New Biologic for Bullous Pemphigoid
Nemolizumab’s Long-Term Data Reinforce Efficacy, Tolerability in Prurigo Nodularis
Topical Ruxolitinib Emerges as Promising Therapy for Diverse Inflammatory Skin Conditions
Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access
Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.
Optimizing Multidisciplinary Care of Patients with Hidradenitis Suppurativa
The Role of Surgery in Hidradenitis Suppurativa
Managing Pain in Patients with Hidradenitis Suppurativa
Ongoing Research in Hidradenitis Suppurativa
Recent Data on Bimekizumab for Hidradenitis Suppurativa
Biologic Therapies for Hidradenitis Suppurativa
The Role of Treatment Guidelines for HS
Hidradenitis Suppurativa (HS): Staging Considerations and Unmet Needs
The Impact of Hidradenitis Suppurativa on Families
Hidradenitis Suppurativa: Addressing the Psychosocial Impact and Hospitalization Rate
Lebrikizumab Shows Promise in Long-Term Atopic Dermatitis Control: Raj Chovatiya, MD, PhD
Using AI as Augmented Intelligence to Improve Rare Dermatologic Skin Diseases
Finding Value in Older, Generic Dermatologic Therapies
Pediatric Alopecia Areata Treatment With Baricitinib, Combination Therapies, Patient Adherence
Atopic Dermatitis Treatment Strategies Using Ruxolitinib, Considering Crucial Role of Skin Microbiome
Patient Education, Provider Education, and Overall Final Thoughts
Navigating New Frontiers: Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria Treatment
The Evaluation of Dupilumab In Chronic Spontaneous Urticaria Treatment
Dr Steve Feldman on How Adverse Event Risks Influence Atopic Dermatitis Treatment Selection
Key Updates Needed in Chronic Spontaneous Urticaria Guidelines
Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
More News
